Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D09SJE
|
|||
Former ID |
DNCL001663
|
|||
Drug Name |
KB002/003
|
|||
Indication | Rheumatoid arthritis [ICD-11: FA20] | Phase 2 | [1] | |
Company |
KaloBios Pharmaceuticals
|
References | Top | |||
---|---|---|---|---|
REF 1 | Clinical pipeline report, company report or official report of KaloBios Pharmaceuticals. | |||
REF 2 | Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues. Genomics 2005 Aug;86(2):127-41. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.